Cellarity Company
Cellarity's platform digitizes the molecular information in cells to elucidate how they behave in health and disease. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.
.png)
.png)
(Reupload).png)
Technology:
Biotechnology, Life Science, Pharmaceutical
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
173000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-02-25
Last Funding Type:
Series B
Register and Claim Ownership